PRIMAQUINE SANOFI 15 mg, film-coated tablet 100 tablets
Active ingredients: Primaquine phosphate, PRIMAQUINE
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Tablet100 tabletsorale
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- PRIMAQUINE SANOFI 15 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 100 comprimés avec kit de reconditionnement
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Feb 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62907143CIP75510136CIP133400955101369Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE DE PRIMAQUINEcomprimé | 26,30 mg · un comprimé | SA |
| PRIMAQUINEcomprimé | 15 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.